From:
kmdi...@comcast.net
[Add to Address Book]
To:
Spin...@yahoogroups.com, jdr...@nejm.org, let...@courant.com,
Jgerb...@cdc.gov, len...@courant.com, motomani...@yahoo.com,
con...@po.state.ct.us, executiv...@nytimes.com,
managin...@nytimes.com, news...@nytimes.com,
the-...@nytimes.com, biz...@nytimes.com, for...@nytimes.com,
me...@nytimes.com, nati...@nytimes.com, spo...@nytimes.com,
dv...@cdc.gov, brigidc...@optonline.net, tr...@hotmail.com,
ubi...@courant.com, spin...@yahoogroups.com, ma...@concentric.net,
camp...@courant.com, jhorn...@fff.org, thomas...@usdoj.gov,
edi...@commondreams.org, kur...@washpost.com, georg...@washpost.com,
hor...@courant.com, commissi...@po.state.ct.us,
cohen...@aol.com, leonar...@po.state.ct.us, FalN...@aol.com,
brans...@comcast.net, vts...@comcast.net, mcne...@aol.com,
o...@po.state.ct.us, da...@davila-dilzer.com,
scott....@po.state.ct.us, attorney...@po.state.ct.us,
patrick....@jud.state.ct.us, thoma...@po.state.ct.us
CC:
fra...@ucia.gov,dr-ahma...@president.ir,
eugener...@washpost.com, dh...@courant.com, hor...@courant.com,
bmi...@newstimes.com, eliot....@oag.state.ny.us, tr...@hotmail.com,
rast...@aol.com, bill...@comcast.net, thomas...@usdoj.gov,
amcg...@rms-law.com, rjmu...@aol.com, paulcrai...@yahoo.com,
sidney_b...@yahoo.com, criminal...@usdoj.gov,
karla.d...@usdoj.gov, christophe...@usdoj.gov,
fra...@ucia.gov, govern...@po.state.ct.us, fit...@gmail.com,
patrick.f...@usdoj.gov, model...@sbcglobal.net
Subject:
Nanobots & Bionic Birdies @ NYMC dot Venture Cap dot guv [SpinLyme]
AMA gets it wrong again
Date:
Tuesday, December 19, 2006 11:50:31 AM
[View Source]
If AMA would look into the matter of who is trying to sell the next
bogus OspA
vaccine, they would find it is Baxter-by-Wormser. The name of this
imaginary
disease (invented by Steere and Kaiser) is Lyme Disease. That's where
the
spirochetes are all trained to attack only knees. These Lyme
spirochetes are
actually Plum Island nanobots. Didn't anyone tell the AMA?
Besides, BigPharma tells *docs* what's a drug and not the other way
around. Now
we have seen Vioxx and Zyprexa are not drugs, and neither was LYMErix.
When
Pfizer found out a vasodilator was having an "adverse effect," they
decided to
call the new disease erectile dysfunction. (It used to be known as
"Beer-Belly"
Disease.)
The drug designs the disease. OspA is the drug, therefore no one can
have Lyme
unless they have an allergy to OspA in a knee.
But, also, no one can have antibodies to OspA and have "Lyme disease."
OspA was
left out of the diagnostics standard:
http://www.cdc.gov/MMWR/preview/mmwrhtml/00038469.htm
OspA is band 31 and OspB is band 34. Do you see them listed there?
NO.
Do you need someone with an MD degree to read that to you?
NO.
So, if AMA can't find any people who have anti-OspA antibodies but
also, *don't*
have anti-OspA antibodies, then that's to be expected. AMA does not
even know
how stupid they are. Now you can believe it because even the lawyers
understand
this is FRAUD, now.
Allen Steere *himself* found antibiotics don't kill all the
spirochetes:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=PureSearch&db=pubmed&details_term=8272083%5BUID%5D
That is the NEW ENGLAND JOURNAL OF MEDICINE, folks.
'Same Jeffrey Drazen NEJM rag that later published that Lyme is
hypochondria
which is cured by placebo effect (by Mark Klempner at BU and the CDC's
Boston
Level IV bioweapons factory).
FDA disclaims their obligation to actually look at the data BigPharma
sends
them.
Why worry about the commentary of arrogant morons at the AMA? The
lawyers
will fix their asses in court, with their own incriminating data, and
the same is happening with the EPA. If AMA
wants to publish junk, let them have it.
When I talked to people in the Phillipines this week I informed them
that the
Russian scientists at New York Medical College are studying the genetic
susceptibilities to diseases in Asian peoples and that they should
inform their
government of this US bioweapons research crime:
VENTURE CAP FIRMS @ New York Medical College:
http://www.actionlyme.org/ALDF_BOARD.htm (click each
jpg a second time to enlarge further)
Durland Fish provides the market analyses for those thugs (Zuckerman,
Greenberg,
and the Walmart Family, Anthony J. Walton):
http://www.google.com/search?hl=en&q=durland+fish+nasa&btnG=Google+Search
That's why it's biotech insider news. These people were invited to the
ALDF's,
Gary Wormser's (IDSA), and Kaiser's American Lyme Disease Association
"GALA," a
fundraiser. It's actually Kaiser and SmithKline at NYMC who are the
central
RICO entity and they have scammed Uncle Sam before *together*:
-----------------------------------------------------
http://myfloridalegal.com/newsrel.nsf/newsreleases/EE15DDE93F7A5DF885256D0B005F4121
GlaxoSmithKline
The U.S. Attorney’s Office for the District of Massachusetts
conducted an
investigation into alleged improprieties relating to the reported best
price for
Flonase, a nasal spray, and Paxil, an anti-depressant. Flonase was
manufactured
and sold by Glaxo Wellcome and Paxil was manufactured and sold by
SmithKline
Beecham. These two companies merged and became GlaxoSmithKline in
December 2001.
Through a private labeling agreement with Kaiser Permanente, an HMO in
California, Glaxo Wellcome manufactured, packaged and shipped Flonase
to Kaiser,
but substituted the Kaiser unique identifying number for the Glaxo
Wellcome
unique identifying number on the label. The purpose of the private
labeling
arrangement was to provide Kaiser additional price discounts on Flonase
without
having to report the discounted price as Glaxo Wellcome’s best
price, thereby
avoiding the obligation to pay additional rebates to Medicaid under the
Medicaid rebate program.
Similarly, SmithKline began the private labeling of Paxil for Kaiser.
Paxil was
manufactured, packaged and shipped by SmithKline to Kaiser, but
SmithKline
substituted Kaiser’s unique identifying number for
SmithKline’s unique
identifying number on the label. SmithKline provided Kaiser additional
price
discounts on Paxil without reporting the newly discounted price to the
Medicaid
rebate program, thereby avoiding payment of additional rebates.
The total civil settlement amounts to $87,600,922 in damages and
penalties to
the federal government and the states. In addition, GlaxoSmithKline
will enter
into a Corporate Integrity Agreement with the U.S. Department of Health
and
Human Services, Office of Inspector General that includes a requirement
to
certify its best price methodology. This will add a new responsibility
for the
manufacturer, enhance future state enforcement and better protect
taxpayer
funds.
--------------------------------------------
This is a legal problem, not a medical problem. We don't know what
medicine is any
more. NIH defaulted, FDA defaulted, CDC defaulted, AMA defaulted, and
so the
only sane thing to do is warn other nations that this is the bullshit
democracy
we intend to spread by genocide and other crimes (Codex Alimentarus-
that's
where no one is allowed to pharm their own nutrients from Mother Earth.
It has
to be packaged and sold by BigPharma.)
What more proof do you need that the AMA is as spineless as the mafia,
than that
they are not saying a word about AbuGhraib, Guantanamo, or the
hypocrisy of Iraq
vs Darfur? *** Not a single one of them has the nuts to stand up to
BushCo.
And how many members does IDSA claim to have? 8,000? ***
The Hypocritic Oath.
AMA is not even worth the keystrokes. They are not worth your time.
And Yale is even worse. They invested in Sudanese oil and only
recently backed
out due to pressure from the students:
http://www.yaledailynews.com/Article.aspx?ArticleID=32049
You know. Yale and the Bushie Bankers of Killingworth. Same dudes who
laundered
money for Pinochet and the 9/11 Saudi hijackers - who were followed
around and
otherwise assisted by the Mossad/Persons with dual American Israeli
citizenship,
and of course, the Bush Brothers Security Firm @ WTC dot thermite dot
com.
The *last* thing Yale or the AMA is about is health. In fact, Lyme was
probably
an accidental release from Durland's Yale's Bioweapons plant on Plum
Island,
because Lyme would otherwise be known as Cape Hateras Disease , that
is, if you
can believe the other BS about it being blown over here on Atlantic
storms on
sea birds:
http://www.cdc.gov/ncidod/eid/vol6no4/rappole.htm
That's a good a story as the "Lyme nanobots only do knees" story of
"Lyme
disease."
The Nanobots and Bionic Birdies School of Medicine @ AMA dot Kaiser dot
guv.
http://www.actionlyme.org/ICC_LYME_CRIME_BARDA_02_December_2005.htm
"Yale owned the patent for OspA or LymeRIX (US Patent No. 5,747,294).
Corixa’s David Persing own this patent, and he only licensed it
to Yale and Imugen, and later
claimed he could not read Western Blots from either Lyme vaccine trial,
2 years
after the publications of the results of those vaccines trials...."
It's all about OspA. Wormser is working for Baxter.
http://www.journals.uchicago.edu/CID/journal/issues/v43n9/40897/40897.html
"Potential conflicts of interest. G.P.W. has received consulting
fees from
Baxter and research support from Immunetics, and he is a founder of
Diaspex, a
company that does not offer products or services. R.J.D. has served as
a speaker
for Pfizer and is part owner of Biopeptides, a biotech company that
develops
vaccines and laboratory diagnostics, including products for Borrelia
burgdorferi. J.J.H. has served as an expert witness on behalf of
Lymerix
(GlaxoSmithKline). A.C.S. has received consulting fees from Baxter.
P.J.K. has a
patent pending with a university on a babesiosis diagnostic procedure
that is
not yet on the market. All other authors: no conflicts."
Now The Worm Guy has his own biotech company.
Same stupid RICO game, different players.
Keep this document. Save as a Word file, because I am tired of
repeating the
same things every single f ing day of my life for 7 years plus:
http://groups.google.com/groups/search?hl=en&ie=UTF-8&oe=UTF-8&q=e-petition+1999++Kathleen&qt_s=Search
http://www.actionlyme.org/USDOJ_COMPLAINT_RICO.htm
http://www.geocities.com/kmdickson0308/lyme-dilemma.html
http://www.fda.gov/ohrms/dockets/ac/01/slides/3680s2.htm
http://www.actionlyme.org/HOW_RICO_WILL_BE_CHARGED.htm
http://www.actionlyme.org/BIOMARKERS.htm
KMD
=====================================
To:
<Spin...@yahoogroups.com>
Subject:
[SpinLyme] AMA gets it wrong again
Date:
Tuesday, December 19, 2006 3:17:09 AM
[View Source]
This AMA reporter should be flooded with emails for misleading and
inaccurate
reporting. A couple of years ago she wrote that Lyme disease only
affects 20,000
or so people a year. I wrote her a letter suggesting she correct this
misinformation and she never did. In fact, she repeats it again here.
[View Source]
NO.
NO.
-----------------------------------------------------
http://myfloridalegal.com/newsrel.nsf/newsreleases/EE15DDE93F7A5DF885256D0B005F4121
GlaxoSmithKline
The U.S. Attorney's Office for the District of Massachusetts
conducted an
investigation into alleged improprieties relating to the reported best
price for
Flonase, a nasal spray, and Paxil, an anti-depressant. Flonase was
manufactured
and sold by Glaxo Wellcome and Paxil was manufactured and sold by
SmithKline
Beecham. These two companies merged and became GlaxoSmithKline in
December 2001.
Through a private labeling agreement with Kaiser Permanente, an HMO in
California, Glaxo Wellcome manufactured, packaged and shipped Flonase
to Kaiser,
but substituted the Kaiser unique identifying number for the Glaxo
Wellcome
unique identifying number on the label. The purpose of the private
labeling
arrangement was to provide Kaiser additional price discounts on Flonase
without
having to report the discounted price as Glaxo Wellcome's best price,
thereby
avoiding the obligation to pay additional rebates to Medicaid under the
Medicaid rebate program.
Similarly, SmithKline began the private labeling of Paxil for Kaiser.
Paxil was
manufactured, packaged and shipped by SmithKline to Kaiser, but
SmithKline
substituted Kaiser's unique identifying number for SmithKline's
--------------------------------------------
The Hypocritic Oath.
Corixa's David Persing own this patent, and he only licensed it to
http://www.actionlyme.org/BIOMARKERS.htm
KMD
=====================================
[View Source]
In one letter to a Lyme victim, an AMA spokeperson wrote that they
devote their
attention to AIDS and other diseases that affect far greater numbers of
people
(untrue) and are serious diseases. They also wrote that Lyme disease
affects
only relatively few people and is not serious. Therefore, they leave
the disease
in the hands of specialty groups (IDSA).
Miki
http://www.ama-assn.org/amednews/2006/12/25/hlsa1225.htm
HEALTH & SCIENCE
Lyme disease debate provokes treatment divide, legal action
In what may be a first, the government has taken steps to investigate
the
drafting of medical guidelines.
By Susan J. Landers, AMNews staff. Dec. 25, 2006.
--------------------------------------------------------------------------------
Washington -- Dueling guidelines developed by two medical organizations
for
treating patients with Lyme disease have sparked such an uproar that
Connecticut's attorney general has stepped in to see if one side ran
afoul of
antitrust statutes.
The Infectious Diseases Society of America and the International Lyme
and
Associated Diseases Society each assembled expert panels that sat down
separately and examined the evidence on the nature of and best
treatment for
this tick-borne illness. But they arrived at different conclusions.
IDSA, a scientific organization of physicians, scientists and other
health care
professionals who specialize in infectious diseases, characterizes Lyme
disease
as primarily acute and treated successfully in the vast majority of
cases with,
at most, a few weeks of antibiotics. ILADS, which is a
multidisciplinary medical
society focused on the diagnosis and treatment of Lyme disease, holds
out the
possibility that the disease is chronic and may need months of
antibiotics.
The differing conclusions call into question how best to treat the more
than
20,000 people who contract the infection each year. Although Lyme
disease has
been reported in nearly all states, most cases are found in the
Northeast,
mid-Atlantic and North Central regions of the nation. Left untreated,
the
infection can spread to joints, the heart and the nervous system,
according to
the Centers for Disease Control and Prevention.
It is not unusual for different medical and scientific groups to take
varying
clinical positions on specific conditions. But this particular
situation quickly
has become far from typical.
[...]
Full text of AMNews content is available to AMA members and paid
subscribers.
Access details Log in Subscribe Join the AMA